Ingevity Corp (NGVT) stock
Close on Nov 12, 2026Market cap $2.13BP/E 36.5Yield –
Ingevity Corp saw revenue fall 3.7% to $1.13B over the twelve months to Sep 30, 2026. Operating income fell 1.7% to $418.70M, moving the operating margin from 36.2% to 37.0%. Free cash flow was $122.60M, down 48.8% from a year earlier. At the latest close the market valued the company at $2.13B, 36.5 times its earnings.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $2.13B
- P/E ratio
- 36.5
- Price to sales
- 1.88
- Price to book
- 33.82
- Dividend yield
- –
- Free cash flow yield
- 5.75%
Fundamentals
- Revenue
- $1.13B
- Net income
- $59.80M
- EPS, diluted
- $1.70
- Free cash flow
- $122.60M
- Book value per share
- $1.81
- Diluted shares
- 35M
Trading
- Next earnings
- Feb 24, 2027 (estimated, after the close)
- Previous close
- $63.24
- Open
- $63.01
- Day's range
- $61.91 – $63.44
- Volume
- 286,290
- Average volume (20 days)
- 402,029
- Index membership
- S&P SmallCap 600 (since Aug 2023), Russell 2000, Russell 3000
- Beta (5 years)
- 1.21
- 52-week range
- $46.38 – $79.28
- RSI (14 days)
- 35.0
- Volatility (1 year)
- 35.2%
- Relative volume
- 1.01×
- WACC
- 9.0%
On 1 of our idea list: Buyback cannibals
Index membership is inferred from the holdings of funds that track each index (SPSM, IJR, IWM, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2016, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | NGVT | S&P 500 | Difference | NGVT per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -10.3% | -2.7% | −7.6 pts | ||
| 3 months | -18.7% | -1.7% | −16.9 pts | ||
| Year to date | +4.7% | +11.9% | −7.2 pts | ||
| 1 year | +26.1% | +12.0% | +14.1 pts | ||
| 3 years | +63.4% | +78.2% | −14.8 pts | +17.8% | +21.2% |
| 5 years | -25.5% | +73.2% | −98.7 pts | -5.7% | +11.6% |
| 10 years | +27.0% | +309.6% | −282.6 pts | +2.4% | +15.1% |
Thirteen years at a glance
Fiscal years 2013 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Ingevity filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Update
- Results
- Results
About Ingevity
Chemicals & Allied Products
Ingevity Corporation develops, manufactures, and markets specialty chemicals and materials. The company operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies. Its offerings include hardwood-based chemically activated carbon products for automotive gasoline vapor emissions control and purification; asphalt pavement additives, road marking materials, and agrochemical dispersants; and caprolactone-based specialty polymers for coatings, elastomers, adhesives, and bioplastics. Ingevity serves global automotive component manufacturers, road construction contractors, agricultural formulation producers, and industrial polymer fabricators.
Company profile, executives and historyIngevity stock: common questions
What is Ingevity's stock price?
NGVT closed at $61.97 on Nov 12, 2026, down 2.01% on the day. Over the past 52 weeks it traded between $46.38 and $79.28.
What is Ingevity's market cap?
Ingevity was worth $2.13B at the close on Nov 12, 2026: the share price times the diluted shares outstanding.
What is NGVT's P/E ratio?
NGVT trades at 36.5 times earnings, based on diluted earnings per share of $1.70 over the twelve months to Sep 30, 2026.
How much revenue does Ingevity make?
Ingevity reported revenue of $1.13B for the twelve months to Sep 30, 2026, down 3.7% from a year earlier.
Does Ingevity pay a dividend?
No. Ingevity has not paid a cash dividend over the last twelve months.
When does Ingevity report earnings next?
Ingevity is expected to report Q4 FY2026 results on Feb 24, 2027, after the close. The date is estimated from its past reporting pattern until the company confirms it.
How has NGVT stock performed over the past year?
Including dividends, NGVT returned +26.1% over the past year, against +12.0% for the S&P 500.
How many NGVT shares are sold short?
1M shares were sold short at the latest FINRA report, 3.69% of the float, or 4.4 days of average trading volume.
Who are Ingevity's competitors?
Companies most similar to Ingevity by business, industry and size include IOSP, BCPC, PRM, ECVT, HUN.
See a number that looks wrong?